• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LR-M 型肝癌的特征和早期复发:与 LR-4 或 5 型肝癌的比较。

Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5.

机构信息

Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

J Magn Reson Imaging. 2021 Nov;54(5):1446-1454. doi: 10.1002/jmri.27650. Epub 2021 Apr 23.

DOI:10.1002/jmri.27650
PMID:33891790
Abstract

BACKGROUND

According to the Liver Imaging Reporting and Data System (LI-RADS), the LI-RADS category M (LR-M), which are probably or definitely malignant but are not specific for hepatocellular carcinomas (HCCs), does not exclude HCCs. A gap in knowledge remains, including their characteristics and recurrence of HCCs categorized as LR-M.

PURPOSE

To compare the characteristics of HCCs categorized as LR-M with HCCs categorized as LR-4 or LR-5 (LR-4/5) using the LI-RADS version 2018 and evaluate the relationship of these categories with the risk of early recurrence after curative resections of single HCCs.

STUDY TYPE

Retrospective.

SUBJECTS

Two hundred and eighty-one patients (mean age, 57 years; 191 men and 90 women) who underwent curative resections for single HCCs and preoperative contrast-enhanced MRI between 2015 and 2017.

FIELD STRENGTH/SEQUENCE: 3T Dual gradient-echo T WI with in- and opposed-phase, turbo spin-echo T WI, diffusion-weighted echo-planar images, and three-dimensional gradient-echo T WI before and after administration of contrast agent.

ASSESSMENT

MRI features according to the LI-RADS version 2018 were evaluated and LI-RADS category were assigned for each observation. Clinical, imaging, and histopathological features were compared based on LI-RADS categorization. Early recurrence rates (<2 years) and associated factors were also evaluated.

STATISTICAL TESTS

Fisher's exact test, two-sample t test after satisfying assumption of normality through Shapiro-Wilk test, Fleiss κ coefficient, Cox proportional hazards regression analysis, Kaplan-Meier method, and log-rank test.

RESULTS

Forty-one HCCs (14.6%) were categorized as LR-M and 240 HCCs (85.4%) were categorized as LR-4/5. LR-M HCCs showed poorer differentiation than LR-4/5 HCCs. In the multivariate analysis, the LR-M category was an independent predictor for early recurrence (hazard ratio, 1.904; 95% confidence interval, 1.024-3.542; P < 0.05). Early recurrence rates were significantly higher in patients with LR-M HCCs than in patients with LR-4/5 HCCs (32.0% vs. 18.4%, respectively, P < 0 05).

DATA CONCLUSION

Compared to LR-4/5 HCCs, LR-M HCCs were associated with poorer tumor differentiation and higher early recurrence rates after curative resections of single HCCs.

LEVEL OF EVIDENCE

3 Technical Efficacy Stage: 2.

摘要

背景

根据肝脏影像报告和数据系统(LI-RADS),LI-RADS 类别 M(LR-M)可能或肯定为恶性,但对肝细胞癌(HCC)不具有特异性,不能排除 HCC。目前仍存在知识空白,包括这些被归类为 LR-M 的 HCC 的特征和 HCC 复发情况。

目的

使用 LI-RADS 版本 2018 比较被归类为 LR-M 的 HCC 与被归类为 LR-4 或 LR-5(LR-4/5)的 HCC 的特征,并评估这些类别与单个 HCC 根治性切除术后早期复发的风险之间的关系。

研究类型

回顾性。

受试者

281 名接受单发性 HCC 根治性切除术并于 2015 年至 2017 年期间进行术前对比增强 MRI 的患者(平均年龄 57 岁;191 名男性和 90 名女性)。

场强/序列:3T 双梯度回波 TWI 同相位和反相位、涡轮自旋回波 TWI、扩散加权回波平面成像,以及三维梯度回波 TWI 于造影剂给药前后。

评估

根据 LI-RADS 版本 2018 评估 MRI 特征,并为每个观察结果分配 LI-RADS 类别。基于 LI-RADS 分类比较临床、影像学和组织病理学特征。还评估了早期复发率(<2 年)及其相关因素。

统计学检验

Fisher 确切检验,Shapiro-Wilk 检验后满足正态性假设的两样本 t 检验,Fleiss κ 系数,Cox 比例风险回归分析,Kaplan-Meier 法和对数秩检验。

结果

41 个 HCC(14.6%)被归类为 LR-M,240 个 HCC(85.4%)被归类为 LR-4/5。LR-M HCC 的分化程度比 LR-4/5 HCC 差。多因素分析显示,LR-M 类别是早期复发的独立预测因子(危险比,1.904;95%置信区间,1.024-3.542;P<0.05)。LR-M HCC 患者的早期复发率明显高于 LR-4/5 HCC 患者(分别为 32.0%和 18.4%,P<0.05)。

数据结论

与 LR-4/5 HCC 相比,LR-M HCC 与单个 HCC 根治性切除术后肿瘤分化程度较差和早期复发率较高相关。

证据水平

3 技术功效分期:2。

相似文献

1
Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5.LR-M 型肝癌的特征和早期复发:与 LR-4 或 5 型肝癌的比较。
J Magn Reson Imaging. 2021 Nov;54(5):1446-1454. doi: 10.1002/jmri.27650. Epub 2021 Apr 23.
2
LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.MRI上的LI-RADS分类与肝内胆管癌术后复发相关:一项多中心研究
J Magn Reson Imaging. 2023 Mar;57(3):930-938. doi: 10.1002/jmri.28354. Epub 2022 Jul 14.
3
Liver Imaging Reporting and Data System Category on Magnetic Resonance Imaging Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation Within the Milan Criteria: A Multicenter Study.磁共振成像 Liver Imaging Reporting and Data System 分类预测米兰标准内肝移植后肝细胞癌复发:一项多中心研究。
Ann Surg Oncol. 2021 Oct;28(11):6782-6789. doi: 10.1245/s10434-021-09772-8. Epub 2021 Mar 9.
4
Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.肝硬化增生性肝细胞癌:LI-RADS 类别 4/5 和类别 M 的患者结局。
Eur Radiol. 2024 May;34(5):2974-2985. doi: 10.1007/s00330-023-10305-y. Epub 2023 Oct 18.
5
Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?肝细胞癌-胆管细胞癌混合型:我们能否使用增强超声肝脏影像报告与数据系统(LI-RADS)来预测患者的生存情况?
Eur Radiol. 2021 Aug;31(8):6397-6405. doi: 10.1007/s00330-020-07656-1. Epub 2021 Jan 25.
6
Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.混合型肝细胞癌:基于肝细胞癌危险因素的磁共振成像特征和预后。
J Magn Reson Imaging. 2021 Jun;53(6):1803-1812. doi: 10.1002/jmri.27528. Epub 2021 Feb 9.
7
LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.LI-RADS 类别与小单发 HCC 的治疗结果相关:手术切除与射频消融。
Eur Radiol. 2024 Jan;34(1):525-537. doi: 10.1007/s00330-023-09998-y. Epub 2023 Aug 1.
8
Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.基于 LI-RADS v2018 的肝细胞癌的 MRI 诊断性能,与 v2017 相比。
J Magn Reson Imaging. 2019 Sep;50(3):746-755. doi: 10.1002/jmri.26640. Epub 2019 Jan 15.
9
A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.一种改良的 LI-RADS:具有增强包膜的靶样肿瘤可被诊断为 HCC,而不是 LR-M 病变。
Eur Radiol. 2022 Feb;32(2):912-922. doi: 10.1007/s00330-021-08124-0. Epub 2021 Aug 4.
10
Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis.单一原发性肝脏恶性肿瘤的根治性切除:肝脏影像报告和数据系统(LI-RADS)分类为LR-M预示着更差的预后。
AJR Am J Roentgenol. 2017 Sep;209(3):576-583. doi: 10.2214/AJR.16.17478. Epub 2017 Jun 28.

引用本文的文献

1
Prognostic and predictive imaging markers of hepatocellular carcinoma: a pictorial essay.肝细胞癌的预后和预测性影像标志物:图文综述
Insights Imaging. 2025 Aug 15;16(1):181. doi: 10.1186/s13244-025-02058-7.
2
LR-M for CT/MRI on LI-RADS v2018: a review of imaging criteria, performance, challenges and future directions from an end-user perspective.基于LI-RADS v2018的CT/MRI肝脏报告和数据系统:从终端用户角度对成像标准、性能、挑战及未来方向的综述
Abdom Radiol (NY). 2025 Aug 14. doi: 10.1007/s00261-025-05132-2.
3
Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion.
钆双胺增强磁共振成像在无微血管侵犯的孤立性切除肝细胞癌中的预后价值
J Hepatocell Carcinoma. 2025 Jul 18;12:1471-1482. doi: 10.2147/JHC.S530701. eCollection 2025.
4
Diagnostic model using LI-RADS v2018 for predicting early recurrence of microvascular invasion-negative solitary hepatocellular carcinoma.使用LI-RADS v2018诊断模型预测微血管侵犯阴性的孤立性肝细胞癌早期复发情况
Cancer Imaging. 2025 Mar 31;25(1):46. doi: 10.1186/s40644-025-00865-1.
5
Assessment of intrahepatic cholangiocarcinoma with LI-RADS in the high-risk population: MRI diagnosis and postoperative survival.高危人群中使用肝脏影像报告和数据系统(LI-RADS)评估肝内胆管癌:MRI诊断及术后生存情况
Cancer Imaging. 2025 Mar 26;25(1):40. doi: 10.1186/s40644-025-00860-6.
6
Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI.基于钆贝葡胺增强MRI对LI-RADS 5类肝细胞癌根治性切除术后微血管侵犯和复发的预测
J Hepatocell Carcinoma. 2024 May 25;11:941-952. doi: 10.2147/JHC.S459686. eCollection 2024.
7
Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis.CT/MRI肝脏影像报告和数据系统(LI-RADS)M类成像特征的阅片者间一致性:一项系统评价和Meta分析
J Liver Cancer. 2024 Sep;24(2):192-205. doi: 10.17998/jlc.2024.04.05. Epub 2024 Apr 15.
8
Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.肝硬化增生性肝细胞癌:LI-RADS 类别 4/5 和类别 M 的患者结局。
Eur Radiol. 2024 May;34(5):2974-2985. doi: 10.1007/s00330-023-10305-y. Epub 2023 Oct 18.
9
LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.LI-RADS 类别与小单发 HCC 的治疗结果相关:手术切除与射频消融。
Eur Radiol. 2024 Jan;34(1):525-537. doi: 10.1007/s00330-023-09998-y. Epub 2023 Aug 1.
10
Radiologic features of hepatocellular carcinoma related to prognosis.肝细胞癌的放射学特征与预后的关系
J Liver Cancer. 2023 Mar;23(1):143-156. doi: 10.17998/jlc.2023.02.16. Epub 2023 Mar 9.